Decreased serum L-arginine and L-citrulline levels in major depression

[1]  M. Koppitz,et al.  Nitric Oxide-Related Biological Pathways in Patients with Major Depression , 2015, PloS one.

[2]  M. B. Moss,et al.  Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients. , 2012, Journal of affective disorders.

[3]  A. Guven,et al.  C-reactive protein and nitric oxide level in patients with white coat hypertension , 2012, Blood pressure.

[4]  Marshall Summar,et al.  Requirement of argininosuccinate lyase for systemic nitric oxide production , 2011, Nature Medicine.

[5]  B. Stephan,et al.  Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: a systematic review. , 2011, Free radical biology & medicine.

[6]  J. Cooke,et al.  DDAH says NO to ADMA. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[7]  S. Bartels,et al.  A Pilot Evaluation of the In SHAPE Individualized Health Promotion Intervention for Adults with Mental Illness , 2010, Community Mental Health Journal.

[8]  Shaghayegh Haghjooy Javanmard,et al.  Effect of L-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits. , 2010, International journal of cardiology.

[9]  J. Loscalzo,et al.  Vascular nitric oxide: formation and function , 2010, Journal of blood medicine.

[10]  Megan E. Piper,et al.  Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. , 2010, Journal of the American College of Cardiology.

[11]  R. Yoshimura,et al.  Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: Comparison between milnacipran and paroxetine , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  L. Manzoli,et al.  Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease , 2009, Clinical pharmacology and therapeutics.

[13]  A. Rizvi.  Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts , 2009, The American journal of the medical sciences.

[14]  M. Van Ameringen,et al.  Paroxetine-induced increase in LDL cholesterol levels , 2009, Journal of psychopharmacology.

[15]  J. Fox,et al.  Argininosuccinate Synthetase Is a Functional Target for a Snake Venom Anti-hypertensive Peptide , 2009, The Journal of Biological Chemistry.

[16]  J Thomas Bigger,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[17]  Alejandro F. Frangi,et al.  Association of endothelial function and vascular data with LDL-c and HDL-c in a homogeneous population of middle-aged, healthy military men: Evidence for a critical role of optimal lipid levels. , 2008, International journal of cardiology.

[18]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[19]  Z. Katusic.  Mechanisms of endothelial dysfunction induced by aging: role of arginase I. , 2007, Circulation research.

[20]  T. Anderson.  Prognostic significance of brachial flow-mediated vasodilation. , 2007, Circulation.

[21]  S. Newman,et al.  Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients , 2006, Neuropsychopharmacology.

[22]  A. Saghatelian,et al.  Assignment of endogenous substrates to enzymes by global metabolite profiling. , 2004, Biochemistry.

[23]  S. Archer,et al.  Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder , 2004, Biological Psychiatry.

[24]  M. Selley.  Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. , 2004, Journal of affective disorders.

[25]  S. Archer,et al.  Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide , 2003, Journal of clinical psychopharmacology.

[26]  Andrew T. Wright,et al.  Detection of endothelial dysfunction with brachial artery ultrasound scanning. , 2003, American heart journal.

[27]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[28]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[29]  J. Lekakis,et al.  Oral L-arginine improves endothelial dysfunction in patients with essential hypertension. , 2002, International journal of cardiology.

[30]  Ren-Ke Li,et al.  A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis , 2002, Circulation.

[31]  J. Ambrose,et al.  Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation. , 2002, Journal of the American College of Cardiology.

[32]  T. Lehtimäki,et al.  Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine , 2001, The Lancet.

[33]  S. Yamashita,et al.  Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. , 2001, The Journal of clinical investigation.

[34]  J. Loscalzo.  An experiment of nature: genetic L-arginine deficiency and NO insufficiency. , 2001, The Journal of clinical investigation.

[35]  J. Sugawara,et al.  Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans. , 2001, Life sciences.

[36]  T. Hagve,et al.  Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. , 2001, The American journal of medicine.

[37]  M. Rapaport.  Prevalence, recognition, and treatment of comorbid depression and anxiety. , 2001, The Journal of clinical psychiatry.

[38]  H. Kumbasar,et al.  Increased serum arginase activity in depressed patients , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[39]  O. Hess,et al.  Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. , 2000, Journal of cardiovascular pharmacology.

[40]  K. Pritchard,et al.  Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. , 1994, Circulation research.

[41]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[42]  K. Vranizan,et al.  Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. , 1985, American journal of epidemiology.

[43]  S. Moore,et al.  Automatic recording apparatus for use in the chromatography of amino acids. , 1958, Federation proceedings.

[44]  D. Atar,et al.  Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study , 2007, Journal of Thrombosis and Thrombolysis.

[45]  S. Moncada,et al.  Nitric oxide and the vascular endothelium. , 2006, Handbook of experimental pharmacology.

[46]  M. López-Figueroa,et al.  Nitric oxide, stress, and depression. , 2001, Psychopharmacology bulletin.

[47]  H. Drexler,et al.  Endothelial Dysfunction in Hypercholesterolemia: Mechanisms, Pathophysiological Importance, and Therapeutic Interventions , 2000, Seminars in thrombosis and hemostasis.